Characteristic | Intervention group (n = 44) | Control group (n = 41) |
---|---|---|
Age, years | 55.8 (10.0) | 55.3 (8.8) |
Body mass, kg | 78.1 (10.1) | 82.9 (17.0) |
Body mass index, kg/m2 | 29.7 (3.5) | 31.1 (5.7) |
Waist circumference, cm | 91.1 (9.9) | 94.5 (13.8) |
Waist:hip ratio | 0.82 (0.07) | 0.83 (0.06) |
Months post treatment | 9.0 (5.5) | 7.1 (4.4) |
Lymphoedema, n (%) | 9 (20.4) | 15 (36.6) |
Ethnicity | Â | Â |
  White, n (%) | 43 (98) | 41 (100) |
Marital status | Â | Â |
  Married/cohabitating, n (%) | 29 (66) | 29 (71) |
  Single/windowed/divorced, n (%) | 15 (34) | 12 (29) |
Smokers, n (%) | 3 (6.8) | 1 (2.4) |
Hormone treatment | Â | |
  Chemotherapy, n (%) | 26 (59.1) | 22 (53.7) |
  Radiotherapy, n (%) | 38 (86.4) | 33 (80.5) |
  Tamoxifen, n (%) | 21 (47.7) | 21 (51.2) |
  Arimidex, n (%) | 14 (31.8) | 10 (24.4) |
  Herceptin, n (%) | 3 (6.8) | 5 (12.2) |